 | Up a level |
Asmis, Lars M; Serra, Andreas; Krafft, Alexander; Licht, Abraham; Leisinger, Elke; Henschkowski-Serra, Jana; Ganter, Michael T; Hauptmann, Steffen; Tinguely, Marianne; Kremer Hovinga, Johanna A (2022). Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 387(25), pp. 2356-2361. Massachusetts Medical Society 10.1056/NEJMoa2211113
Meihandoest, Tamana; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Amstutz, Ursula; Bovet, Cedric; Sauter, Thomas C; Asmis, Lars M; Nagler, Michael (2022). Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. Frontiers in cardiovascular medicine, 9, p. 817826. Frontiers 10.3389/fcvm.2022.817826
Fontana, Pierre; Alberio, Lorenzo; Albisetti, Manuela; Angelillo, Anne; Asmis, Lars M; Casini, Alessandro; Gerber, Bernhard; Graf, Lukas; Hegemann, Inga; Korte, Wolfgang; Martinez, Maria; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Kremer Hovinga, Johanna A. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss medical weekly, 150, w20422. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20422
Fontana, Pierre; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Asmis, Lars M; Korte, Wolfgang; Mendez, Adriana; Schmid, Pirmin; Stricker, Hans; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Nagler, Michael (2017). Impact of rivaroxaban on point-of-care assays. Thrombosis research, 153, pp. 65-70. Elsevier 10.1016/j.thromres.2017.03.019
Asmis, Lars M; Asmis, Reto; Sulzer, Irmela; Furlan, Miha; Lämmle, Bernhard (2008). Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity? Swiss medical weekly, 138(9-10), pp. 142-9. Muttenz: EMH Schweizerischer Ärzteverlag
